Antimicrobial Therapy in Veterinary Medicine 2013
DOI: 10.1002/9781118675014.ch4
|View full text |Cite
|
Sign up to set email alerts
|

Principles of Antimicrobial Drug Bioavailability and Disposition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
29
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(31 citation statements)
references
References 55 publications
1
29
0
1
Order By: Relevance
“…Therapeutic treatment by injection will achieve more predictable plasma drug levels, enhancing opportunities for disease control (Baggot 2007; Lees et al 2006). In cases where individual treatment is difficult, such as with large poultry operations, improving husbandry and hygiene at production facilities are preferred over the administration of oral therapeutic antimicrobial with veterinary supervision, and all are preferable to FCMF without veterinary supervision.…”
Section: Resultsmentioning
confidence: 99%
“…Therapeutic treatment by injection will achieve more predictable plasma drug levels, enhancing opportunities for disease control (Baggot 2007; Lees et al 2006). In cases where individual treatment is difficult, such as with large poultry operations, improving husbandry and hygiene at production facilities are preferred over the administration of oral therapeutic antimicrobial with veterinary supervision, and all are preferable to FCMF without veterinary supervision.…”
Section: Resultsmentioning
confidence: 99%
“…The concentration attained at the desired target tissue depends on the delivery process of the drug to the tissues and the ability of the drug to penetrate capillary endothelium and diffuse across cell membranes [25], where factors such as lipophilicity and the binding of the drug to plasma proteins and other tissue components play a critical role [26]. Therefore, the tissue distribution process varies widely for different drug molecules and has to be studied in each case [27].…”
Section: Discussionmentioning
confidence: 99%
“…Multiple consecutive administrations could result in different pharmacokinetics and/or nephrotoxicity due to drug accumulation. Although there are available data on the pharmacokinetics of aminosidine in clinically normal dogs (Belloli et al, 1999), it is well known that disease states, like CanL, may alter the absorption and disposition of drugs and thus, profoundly affect clinical efficacy and/or toxicity (Baggot, 2006). Furthermore, the combination of aminosidine and antimony administered in this study (Belloli et al, 1999) may have resulted in a different pharmacokinetic profile compared to the administration of aminosidine alone due to possible drug interactions.…”
Section: Introductionmentioning
confidence: 90%
“…Initial clinical trials, have shown that aminosidine, usually administered twice daily, is effective for the treatment of CanL (Baggot, 2006;Belloli et al, 1999;Martinez, 1998;Oliva et al, 1998;Poli et al, 1997;Vexenat et al, 1998) but at the same time toxic for the host. Later on, advances in understanding the mechanisms of aminoglycoside mode of action and toxicity contributed to the modification of their dose schedules in order to increase efficacy and prevent toxicity.…”
Section: Introductionmentioning
confidence: 99%